Emerging Infectious Disease ISSN: 1080-6059

Eliminating Trachoma in Areas with Limited Disease

Bruce D. Gaynor*, Yinghui Miao*, Vicky Cevallos*, Hem Jha†, JSP Chaudary†, Ramesh Bhatta†, Susan Osaki-Holm*, Elizabeth Yi*, Julius Schachter*, John P. Whitcher*, and Thomas Lietman*

Author affiliations: *University of California, San Francisco, San Francisco, California, USA; †Geta Eye Hospital, Geta, Nepal

Main Article

Figure

The prevalence of clinically active trachoma (gray curve) and ocular chlamydial infection, as determined by DNA amplification tests (black curve, with 95% confidence intervals due to stratified sampling) in children 1–10 years of age in a village in Western Nepal over time. All children were examined at each visit, so no sampling confidence interval is indicated. Likewise, conjunctivae of all children were swabbed for evidence of infection at the May 2001 visit.

Figure. The prevalence of clinically active trachoma (gray curve) and ocular chlamydial infection, as determined by DNA amplification tests (black curve, with 95% confidence intervals due to stratified sampling) in children 1–10 years of age in a village in Western Nepal over time. All children were examined at each visit, so no sampling confidence interval is indicated. Likewise, conjunctivae of all children were swabbed for evidence of infection at the May 2001 visit.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.